Redcare Pharmacy N.V.
SHPPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,371 | $1,799 | $1,204 | $1,060 |
| % Growth | 31.8% | 49.4% | 13.6% | – |
| Cost of Goods Sold | $1,825 | $1,358 | $873 | $794 |
| Gross Profit | $546 | $440 | $332 | $267 |
| % Margin | 23% | 24.5% | 27.5% | 25.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $41 | $33 | $27 | $21 |
| SG&A Expenses | $357 | $267 | $244 | $197 |
| Sales & Mktg Exp. | $315 | $234 | $218 | $176 |
| Other Operating Expenses | $228 | $190 | $0 | $0 |
| Operating Expenses | $585 | $458 | $401 | $332 |
| Operating Income | -$39 | -$17 | -$69 | -$66 |
| % Margin | -1.6% | -1% | -5.7% | -6.2% |
| Other Income/Exp. Net | -$9 | $3 | -$15 | -$12 |
| Pre-Tax Income | -$48 | -$14 | -$84 | -$78 |
| Tax Expense | -$1 | -$3 | -$6 | -$4 |
| Net Income | -$45 | -$12 | -$78 | -$74 |
| % Margin | -1.9% | -0.7% | -6.4% | -7% |
| EPS | -2.26 | -0.63 | -4.32 | -4.15 |
| % Growth | -258.7% | 85.4% | -4.1% | – |
| EPS Diluted | -2.26 | -0.63 | -4.32 | -4.15 |
| Weighted Avg Shares Out | 20 | 19 | 18 | 18 |
| Weighted Avg Shares Out Dil | 20 | 19 | 18 | 18 |
| Supplemental Information | – | – | – | – |
| Interest Income | $6 | $5 | $0 | $0 |
| Interest Expense | $8 | $8 | $9 | $9 |
| Depreciation & Amortization | $68 | $57 | $40 | $27 |
| EBITDA | $28 | $51 | -$36 | -$42 |
| % Margin | 1.2% | 2.8% | -3% | -4% |